CC
LLY icon

Chase Coleman’s Eli Lilly LLY Stock Holding History

Chase Coleman’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,511,160
Closed -$1.18B – 58
2025
Q2 		$1.18B Buy
1,511,160
+176,200
+13% +$137M 3.46% 8
2025
Q1 		$1.1B Buy
1,334,960
+25,000
+2% +$20.8M 4.15% 8
2024
Q4 		$1.01B Buy
1,309,960
+340,160
+35% +$282M 3.82% 9
2024
Q3 		$859M Buy
969,800
+39,800
+4% +$35.8M 3.67% 10
2024
Q2 		$842M Buy
930,000
+40,000
+4% +$32M 3.89% 10
2024
Q1 		$692M Hold
890,000
– – 3.78% 9
2023
Q4 		$519M Sell
890,000
-29,100
-3% -$17M 3.69% 9
2023
Q3 		$494M Buy
919,100
+195,000
+27% +$100M 3.64% 9
2023
Q2 		$340M Buy
+724,100
New +$304M 2.84% 11

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Chase Coleman's LLY Position: Q3 2025 in Review

Chase Coleman sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 1,511,160 shares — an estimated $1.18B sold.

Chase Coleman first reported a position in LLY in Q2 2023 and held it in 9 quarters. The position peaked at $1.18B in Q2 2025. 3,900 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Chase Coleman reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Chase Coleman sold 1,511,160 Eli Lilly shares in Q3 2025, an estimated $1.18B.
  • Chase Coleman first reported a position in Eli Lilly in Q2 2023 and held it in 9 quarters.
  • Chase Coleman's Eli Lilly position peaked at $1.18B in Q2 2025.
  • 3,900 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Tiger Global Management's 13F filing for Q3 2025, filed 14 Nov 2025.